Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

SARS-CoV-2 mRNA疫苗可快速稳定地动员CD8+ T细胞

阅读:2
作者:Valerie Oberhardt # ,Hendrik Luxenburger # ,Janine Kemming # ,Isabel Schulien # ,Kevin Ciminski ,Sebastian Giese ,Benedikt Csernalabics ,Julia Lang-Meli ,Iga Janowska ,Julian Staniek ,Katharina Wild ,Kristi Basho ,Mircea Stefan Marinescu ,Jonas Fuchs ,Fernando Topfstedt ,Ales Janda ,Oezlem Sogukpinar ,Hanna Hilger ,Katarina Stete ,Florian Emmerich ,Bertram Bengsch ,Cornelius F Waller ,Siegbert Rieg ,Sagar ,Tobias Boettler ,Katharina Zoldan ,Georg Kochs ,Martin Schwemmle ,Marta Rizzi ,Robert Thimme ,Christoph Neumann-Haefelin ,Maike Hofmann

Abstract

SARS-CoV-2 spike mRNA vaccines1-3 mediate protection from severe disease as early as ten days after prime vaccination3, when neutralizing antibodies are hardly detectable4-6. Vaccine-induced CD8+ T cells may therefore be the main mediators of protection at this early stage7,8. The details of their induction, comparison to natural infection, and association with other arms of vaccine-induced immunity remain, however, incompletely understood. Here we show on a single-epitope level that a stable and fully functional CD8+ T cell response is vigorously mobilized one week after prime vaccination with bnt162b2, when circulating CD4+ T cells and neutralizing antibodies are still weakly detectable. Boost vaccination induced a robust expansion that generated highly differentiated effector CD8+ T cells; however, neither the functional capacity nor the memory precursor T cell pool was affected. Compared with natural infection, vaccine-induced early memory T cells exhibited similar functional capacities but a different subset distribution. Our results indicate that CD8+ T cells are important effector cells, are expanded in the early protection window after prime vaccination, precede maturation of other effector arms of vaccine-induced immunity and are stably maintained after boost vaccination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。